High-intensity focused ultrasound (HIFU) is a noninvasive way to destroy tissue or stop it from working. It was approved by the U.S. Food and Drug Administration for prostate ablation in 2015, but the ...

I'll be honest - I wasn't particularly keen on the idea. A full-body health scan? At my age? I'm 46, eat properly, I don't ...

Scan.com, a UK-based platform, offers access to private diagnostic scans, including MRI, ultrasound, and CT scans, conducted ...

Scan.com is a UK-based platform that provides access to private diagnostic scans, including MRI, ultrasound and CT scans, ...

Being diagnosed with cancer is one of the scariest things imaginable. But a cancer diagnosis doesn't have to be a death ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company") is pleased to announce that it has completed its previously announced private placement ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) is pleased to announce that it has increased the size of its private placement previously announced on December 19, 2025 ...

Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announced that it has been selected as a winner of the 2025 ...

LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announced that it has been selected ...

Profound Medical Corp. (Nasdaq:PROF; TSX:PRN) (“Profound” or the “Company”) today announced the sale of 5,142,857 common shares at a purchase price of $7.00 ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) today announced the closing of its previously announced registered direct offering of 5,142,870 common ...